UNSPSC 51102835: Ciprofloxacin/dexamethasone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102835 Ciprofloxacin/dexamethasone is a Commodity code representing pharmaceutical products and formulations procured by state and local health departments and county public health agencies. Recent state and local solicitations show active purchasing of ciprofloxacin in tablet form (notably ciprofloxacin hydrochloride 500mg) supplied through pharmaceutical warehouse contracts and cooperative purchasing vehicles. The work spans pharmaceutical procurement, inventory management through designated vendors, and scheduled delivery to public health facilities and community health centers. Issuing bodies include state departments of public health and county health agencies that source medications to support public health programs and community health initiatives.

The most recent activity concentrates in Illinois and Florida. The Illinois Department of Public Health completed an IFB award in August 2026 to Chartwell Rx LLC for ciprofloxacin hydrochloride 500mg tablets (20-count packages, 60-month expiration) and doxycycline through the MMCAP Infuse cooperative purchasing consortium; the award totaled $2,999,999.11 over 12 months with two optional renewal years. Seminole County, Florida issued an IFB in June 2026 seeking annual procurement of naloxone and safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford; while that solicitation emphasizes naloxone over ciprofloxacin, it reflects the broader pattern of county health authorities sourcing pharmaceutical and medical supplies through competitive sealed bidding with fixed terms and renewal options.